[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hba1c-level\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hba1c-level":78},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100623423",false,"NCT07396441","Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye","Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye.","HONEY-JOAG","Inclusion Criteria:\n\nJOAG patients age 15 years old and above until 40 years old at the time of diagnosis Compliant to conventional treatment achieved target intraocular pressure\n\nExclusion Criteria:\n\nPatients with allergy to honey or honey-based products OCT signal less than 6\u002F10 Concurrent retinal diseases and other optic neuropathies Systemic neurodegenerative disease Systemic comorbidities such as diabetes mellitus and autoimmune diseases Patients on other honey-based products for the last 3 months Patient who consumes honey-based products during the study duration of 3 months (monitoring via honey-diary, return of the used sachet during the follow up visits) Patients on anti-oxidants, traditional medications or herbal products for the last 3 months Topical usage of steroids, systemic steroids and non-steroidal anti-inflammatory drugs.\n\nSepsis Compliance less than 75%.","ALL","15 Years","40 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","The goal of this clinical trial is to evaluate the effects of stingless bee honey (Kelulut honey) in juvenile open-angle glaucoma patients. The study evaluates the effects on serum Interleukin 6 level(IL-6), retinal nerve fiber layer(RNFL) thickness and dry eye-related symptoms. A total of 60 participants who meet the study criteria will be randomly assigned to one of two groups. One group will consume 30 grams of Kelulut honey daily for a period of three months, while the control group will not receive honey or a placebo. Serum IL-6 level, RNFL thickness, Tear break up time (TBUT) and Schirmer Test 1 will be done before and after 90 days. Adherence to honey consumption will be monitored using a daily diary. This study aims to provide better understanding of the potential role of Kelulut honey as a supplementary therapy in patients with juvenile open-angle glaucoma.",[27,28,29,30,31],"Juvenile Open Angle Glaucoma","Dry Eye Disease (DED)","Interleukin 6","Retinal Nerve Fiber Layer Thickness","HbA1c Level","RECRUITING","2026-02-03",{"date":35,"type":36},"2026-02-09","ACTUAL",{"date":38,"type":36},"2026-01-15",{"date":40,"type":21},"2026-06-30",{"name":42,"class":43},"Universiti Sains Malaysia","OTHER",4,{"id":46,"slug":4,"hasResults":10,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":10,"sex":16,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":57,"conditions":58,"keywords":64,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":5},"100569921","NCT06700525","StandUPTV Habits: Feasibility Trial for Maintaining Reductions in Sedentary Screen Time","SUTV Habits","Inclusion Criteria:\n\n* Insufficiently active as defined by not meeting current US National Guidelines for Physical Activity of 150 minutes of MVPA\u002Fweek (Measured by the Stanford\n* Leisure-Time Activity Categorical Item)\n* \\> 3 hours of SST per day\n* Use Android (8.0+) smartphone (8.0+ represents 95% of Android device coverage per https:\u002F\u002Fapilevels.com\u002F)\n* Have regular broadband internet in their home or an unlimited data plan\n* Able to read\u002Funderstand English (\\>5th grade literacy)\n* Willing to download StandUPTV Habits\n* Willing to wear activPAL and CGM device during study assessment periods\n* Willing to have data shared in de-identified form in Dexcom Clarity platform\n* Willing to be randomized to either study condition\n* Not traveling overnight or longer in the next 4 months\n\nExclusion Criteria:\n\n* Planned relocation\n* Current smoker\n* Have a major illness (e.g., heart disease, cancer, renal disease) for which MVPA is contraindicated\n* Diagnosed with diabetes or gestational diabetes in the past\n* Currently using a CGM\n* Pregnant\n* Occupation that requires substantial use of personal device for media-related activities (e.g., social media)\n* Drug abuse\n* Serious psychological disorder\n* Not willing to use Fitbit or smart plugs for calculation of sedentary screen time for functionality of StandUPTV app","23 Years","64 Years",{"count":54,"type":21},48,[56],"NA","Our goal in this study is to further refine StandUPTV, an application designed to reduce SST in adults in our first study (ASU IRB # STUDY00012109), for the StandUPTV Habits program. This program aims to establish a non-sedentary habit triggered by an alert from the StandUPTV application after participants engage in approximately 30 minutes of SST in the evening.",[59,60,61,62,63,31],"Sedentary Behaviors","Screen Time","Physical Activity","Glucose Metabolism","Sleep Quality",[65,66,67,68],"sedentary behavior","action planning","evening sedentary screen time","mHealth","2026-01-08",{"date":71,"type":36},"2026-01-12",{"date":73,"type":36},"2025-07-01",{"date":75,"type":21},"2026-12-15",{"name":77,"class":43},"Arizona State University",""]